Pharma exports pick up in August; but still down compared to last year

G Naga Sridhar Hyderabad | Updated on January 10, 2018

The decline in pharmaceutical exports during April - July this year has been halted as they registered a 4 per cent increase in August compared to same period last year.

This was disclosed by Madan Mohan Reddy, Chariman, Pharmaceutical Export Promotion Council (Pharmexcil) and its Director-General Ravi Uday Bhaskar on the sidelines of the 13th annual meeting of the Pharmexcil held here on Saturday.

``During April-July, pharma exports declined 7.9 per cent. This trend, however, was reversed in August which showed 4 per cent growth,’’ Reddy, who is also Director, Aurobindo Pharma Ltd, said.

However, over all exports during April - August 2017 were still lower by 4 per cent when compared to same period last year.

The decline could be due to regulatory issues faced by some companies, pricing pressure in the US and also a temporary impact of Good and Services Tax (GST), according to pharmexcil.

When asked on the likely trend for the full year of 2017-18, Uday Bhaskar said the council was expecting ``some’’ growth this year unlike last year in which the exports were flat at $16.84 billion.

The Pharmexcil is working along with Government of India, industry and research institutions for import substitution as Indian pharma industry now has a significant dependency on imports of Active Pharmaceutical Ingredients (APIs) and intermediates among others.

The draft of the proposed new pharma policy has also mooted a provision to keep drugs made from import substituted APIs out of the purview of drug price control for a period of five years, Dinesh Dua, Vice Chairman, Pharmexcil and CEO of Nectar Life Sciences Ltd.

Published on September 23, 2017

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor